Fig. 3.
Mean decline in HCV RNA from baseline to week 6. bid twice daily, PR peginterferon alfa-2a and ribavirin. *Administered with peginterferon alfa-2a and ribavirin
Mean decline in HCV RNA from baseline to week 6. bid twice daily, PR peginterferon alfa-2a and ribavirin. *Administered with peginterferon alfa-2a and ribavirin